Immunostimulants are gradually being used in the prevention and treatment of recurrent respiratory tract infections in susceptible children, but their drug effects have not been quantified. The purpose of this study was to confirm the efficacy of immunostimulants in the prevention and treatment of recurrent respiratory tract infections in susceptible children. A model-based meta-analysis was used to describe the time course of placebo and immunostimulants in the prevention of respiratory tract infections in children. The cumulative number of respiratory tract infections was used as an indicator of efficacy. Learners that complete this educational event will be able to articulate the efficacy of immunostimulants in the prevention and treatment of recurrent respiratory tract infections in susceptible children.
- Provider:American College of Clinical Pharmacology
- Activity Link: https://accp1.org/ACCP1/Events/Event_Display.aspx?EventKey=WEB2022_1
- Start Date: 2022-02-01 06:00:00
- End Date: 2022-02-01 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: No
- Activity Type: Journal-based CE
- CME Finder Type: Other
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all